Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection: An effective and safe alternative to surgery

Annals of the American Thoracic Society

Volumn 11, Issue 9, 2014, Pages 1419-1425

  Piccolo, Francesco ^a   Pitman, Nicholas ^b   Bhatnagar, Rahul ^c   Popowicz, Natalia ^d   Smith, Nicola A ^e   Brockway, Ben ^f   Nickels, Robert ^g   Burke, Andrew J ^h   Wong, Conroy A ⁱ   McCartney, Ruth ^j   Choo Kang, Brian ^k   Blyth, Kevin G ^l   Maskell, Nick A ^c   Lee, Y C Gary ^d,m  

^a Swan District Hospital   (Australia)

^b CROSSHOUSE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^e WELLINGTON HOSPITAL   (New Zealand)

^f UNIVERSITY OF OTAGO   (New Zealand)

^g Tweed Heads Hospital   (Australia)

^h THE PRINCE CHARLES HOSPITAL   (Australia)

ⁱ MIDDLEMORE HOSPITAL   (New Zealand)

^j GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^k GLASGOW ROYAL INFIRMARY   (United Kingdom)

^l SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^m UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

more..

Author keywords

Deoxyribonuclease; Empyema; Fibrinolytic; Infection; Pleural; Tissue plasminogen activator

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; DEOXYRIBONUCLEASE; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; FIBRINOLYTIC AGENT;

ADULT; ARTICLE; BLEEDING; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; HUMAN; LUNG CLEARANCE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAIN; PLEURA FLUID; PLEURISY; RANDOMIZED CONTROLLED TRIAL; THORAX DRAINAGE; THORAX RADIOGRAPHY; TREATMENT DURATION; CLINICAL TRIAL; DRAINAGE; DRUG INSTILLATION; EMPYEMA, PLEURAL; MIDDLE AGED; PROSPECTIVE STUDY;

C-REACTIVE PROTEIN; DEOXYRIBONUCLEASES; DRAINAGE; EMPYEMA, PLEURAL; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INSTILLATION, DRUG; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOGRAPHY, THORACIC; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84914674375     PISSN: 23296933     EISSN: 23256621     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201407-329OC     Document Type: Article

References (18)

1. Davies HE, Davies RJO, Davies CWH; the BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010. Thorax 2010;65 (suppl 2):ii41-ii53.
2. Bouros D, Schiza S, Patsourakis G, Chalkiadakis G, Panagou P, Siafakas NM. Intra pleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: A prospective, double-blind study. Am J Respir Crit Care Med 1997;155:291-295.
3. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intra pleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema: A randomized, double-blind study. Am J Respir Crit Care Med 1999;159:37-42.
4. Thommi G, Shehan JC, Robison KL, Christensen M, Backemeyer LA, McLeay MT. A double blind randomized cross over trial comparing rate of decortication and efficacy of intra pleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions. Respir Med 2012;106:716-723.
5. Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intra pleural streptokinase in community acquired pleural infection. Thorax 1997;52:416-421.
6. Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intra pleural streptokinase for empyema and complicated par apneumonic effusions. Am J Respir Crit Care Med 2004;170: 49-53.
7. Moulton JS, Benkert RE, Weisiger KH, Chambers JA. Treatment of complicated pleural fluid collections with image-guided drainage and intra cavitary urokinase. Chest 1995;108:1252-1259.
8. Maskell NA, Davies CW, Nunn AJ, Hedley EL, Gleeson FV, Miller R, Gabe R, Rees GL, Peto TE, Woodhead MA, et al.; First Multicenter Intra pleural Sepsis Trial (MIST1) Group. U.K. controlled trial of intra pleural streptokinase for pleural infection. N Engl J Med 2005; 352:865-874.
9. Rahman NM, Maskell NA, West A, Teoh R, Arnold A, Mackinlay C, Peckham D, Davies CW, Ali N, Kinnear W, et al. Intra pleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011;365:518-526.
10. Finley C, Clifton J, Fitzgerald JM, Yee J. Empyema: An increasing concern in Canada. Can Respir J 2008;15:85-89.
11. Farjah F, Symons RG, Krishnadasan B, Wood DE, Flum DR. Management of pleural space infections: A population-based analysis. J Thorac Cardiovasc Surg 2007;133:346-351.
12. Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 2000;117:1728-1733.
13. Zhu Z, Hawthorne ML, Guo Y, Drake W, Bilaceroglu S, Misra HL, Light RW. Tissue plasminogen activator combined with human recombinant deoxyribonuclease is effective therapy for empyema in a rabbit model. Chest 2006;129:1577-1583.
14. Clementsen P, Evald T, Grode G, Hansen M, Krag Jacobsen G, Faurschou P. Treatment of malignant pleural effusion: pleurodesis using a small percutaneous catheter: A prospective randomized study. Respir Med 1998;92:593-596.
15. Rahman NM, Maskell NA, Davies CW, Hedley EL, Nunn AJ, Gleeson FV, Davies RJ. The relationship between chest tube size and clinical outcome in pleural infection. Chest 2010;137:536-543.
16. Innes A, Burden RP, Finch RG, Morgan AG. Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intra peritoneal urokinase: A double-blind clinical trial. Nephrol Dial Transplant 1994;9:797-799.
17. TongMK, Leung KT, Siu YP, Lee KF, Lee HK, Yung CY, Kwan TH, Au TC. Use of intra peritoneal urokinase for resistant bacterial peritonitis in continuous ambulatory peritoneal dialysis. J Nephrol 2005;18:204-208.
18. Chung CL, Chen CH, Sheu JR, Chen YC, Chang SC. Pro inflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates. Chest 2005; 128:690-697.